U.S. Markets open in 7 hrs 30 mins

NanoString Technologies, Inc. (NSTG)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
68.88-5.27 (-7.11%)
At close: 4:00PM EST
Full screen
Loading interactive chart...
  • NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

    NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates

    NanoString (NSTG) delivered earnings and revenue surprises of -12.77% and 1.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Benzinga

    Recap: NanoString Technologies Q4 Earnings

    Shares of NanoString Technologies (NASDAQ:NSTG) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 15.87% year over year to ($0.53), which missed the estimate of ($0.49). Revenue of $36,262,000 decreased by 1.81% from the same period last year, which beat the estimate of $34,650,000. Looking Ahead NanoString Sees FY21 Sales $140M-$150M vs $151.03M Est. How To Listen To The Conference Call Date: Mar 01, 2021 Time: 04:30 PM View more earnings on NSTG ET Webcast URL: https://www.directeventreg.com/registration/event/3093307 Technicals 52-week high: $86.42 Company's 52-week low was at $13.85 Price action over last quarter: Up 88.64% Company Overview NanoString Technologies Inc is a biotechnology company involved in translational research and molecular diagnostics. The product portfolio is based on a novel digital molecular barcoding technology. This technology, nCounter Analysis System, uses molecular barcodes and single-molecule imaging to distinguish and count hundreds of unique transcripts in a single reaction. Geographically, it derives maximum revenue from the Americas and also has a presence in Europe and Middle East, and the Asia Pacific. Other products and services include Analysis Solutions, GeoMx Digital Spatial Profiler, Gene Expression, Vantage 3D Assays, Sample Prep, and nCounter Consumables. The system is used for performing cancer research, biomarker validation and screening, and next-generation sequencing validation. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For March 1, 2021A Preview Of NanoString Technologies's Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.